FR1571341A - - Google Patents

Info

Publication number
FR1571341A
FR1571341A FR1571341DA FR1571341A FR 1571341 A FR1571341 A FR 1571341A FR 1571341D A FR1571341D A FR 1571341DA FR 1571341 A FR1571341 A FR 1571341A
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR1571341A publication Critical patent/FR1571341A/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR1571341D 1966-12-28 1967-12-28 Expired FR1571341A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB5796367 1966-12-28
GB57963/66A GB1138405A (en) 1966-12-28 1966-12-28 Morpholine derivatives

Publications (1)

Publication Number Publication Date
FR1571341A true FR1571341A (fr) 1969-06-20

Family

ID=26267707

Family Applications (2)

Application Number Title Priority Date Filing Date
FR1571341D Expired FR1571341A (fr) 1966-12-28 1967-12-28
FR145697A Expired FR7557M (fr) 1966-12-28 1968-03-27

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR145697A Expired FR7557M (fr) 1966-12-28 1968-03-27

Country Status (7)

Country Link
US (1) US3714161A (fr)
BE (1) BE708557A (fr)
CH (1) CH504452A (fr)
DE (1) DE1695295C2 (fr)
FR (2) FR1571341A (fr)
GB (1) GB1138405A (fr)
NL (1) NL157303B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2073375A2 (fr) * 1969-11-17 1971-10-01 Ici Ltd

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959273A (en) * 1966-12-28 1976-05-25 Imperial Chemical Industries Limited Morpholine derivatives
US3857839A (en) * 1969-06-20 1974-12-31 Ici Ltd For cyclising 1-aryloxy-3 beta-substituted ethylamino-2-propanols
BE758766A (fr) * 1969-11-17 1971-05-10 Ici Ltd Nouveaux derives de la morpholine et de la
US3806595A (en) * 1971-08-09 1974-04-23 Ici Ltd Method of producing anorexia
GB1382526A (en) * 1972-08-11 1975-02-05 Ici Ltd Morpholine derivatives
US4079135A (en) * 1973-12-13 1978-03-14 Imperial Chemical Industries Limited Morpholine derivatives as antidepressants
US4033951A (en) * 1973-12-13 1977-07-05 Imperial Chemical Industries Limited Morpholine derivative of a 1,4-benzothiazin-3-one
CA1064927A (fr) * 1975-01-29 1979-10-23 Yuji Kawashima Procede pour la production de derives de la 2-indenyloxymethymorpholine
US4109088A (en) * 1975-01-29 1978-08-22 Yamanouchi Pharmaceutical Co., Ltd. 2-(indenyloxymethyl) morpholine derivatives
US4005084A (en) * 1975-07-10 1977-01-25 Yoshitomi Pharmaceutical Industries, Ltd. Thienylmethyl phenoxy morpholine compounds
DE2530860A1 (de) * 1975-07-10 1977-01-20 Yoshitomi Pharmaceutical 2-phenoxymethylmorpholin-derivate
IL56369A (en) * 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
US4241059A (en) * 1979-12-17 1980-12-23 E. R. Squibb & Sons, Inc. 6-[(Aryloxy)methyl]-2-morpholinemethanol derivatives and use thereof
FR2534915B1 (fr) * 1982-10-26 1985-10-25 Lafon Labor Nouveaux derives de 2-(phenoxymethyl)-morpholine, utilisation en therapeutique et procede de preparation
FR2575158B1 (fr) * 1984-12-20 1987-10-02 Pf Medicament Arylalcoyloxymethyl-2 morpholines, leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central
FR2612926B1 (fr) * 1987-03-24 1989-06-09 Adir Nouveaux derives de la morpholine, leur procede de preparation et les compositions pharmaceutiques les renfermant
AU3364493A (en) * 1992-01-28 1993-09-01 Smithkline Beecham Plc Compounds as calcium channel antagonists
AU670675B2 (en) * 1993-02-10 1996-07-25 Yamanouchi Pharmaceutical Co., Ltd. Morpholine derivative
US7294637B2 (en) 2000-09-11 2007-11-13 Sepracor, Inc. Method of treating addiction or dependence using a ligand for a monamine receptor or transporter
AU9087301A (en) 2000-09-11 2002-03-26 Sepracor Inc Ligands for monoamine receptors and transporters, and methods of use thereof
BRPI0510453A (pt) 2004-04-30 2007-10-30 Warner Lambert Co composto substituìdos com morfolina para o tratamento de distúrbios do sistema nervoso central
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds
GEP20125425B (en) 2006-10-18 2012-03-26 Pfizer Prod Inc Biaryl ether urea compounds
CA2735934C (fr) 2008-09-05 2014-01-07 Supernus Pharmaceuticals, Inc. Procede de traitement de trouble deficitaire de l'attention avec hyperactivite (adhd)
MX355697B (es) 2010-04-12 2018-04-27 Supernus Pharmaceuticals Inc Métodos para producir sales de viloxazina y polimorfos novedosos de las mismas.
JP5952267B2 (ja) 2010-05-21 2016-07-13 リサーチ・トライアングル・インスティチュート 薬物依存を処置するためのヒドロキシブプロピオン類似体（政府支援研究または開発）
JP2013526583A (ja) 2010-05-21 2013-06-24 リサーチ・トライアングル・インスティチュート フェニルモルホリンおよびその類似体
MX356727B (es) 2012-02-08 2018-06-12 Supernus Pharmaceuticals Inc Formulaciones de liberacion modificada de viloxacina.
EP4317141A1 (fr) 2022-08-04 2024-02-07 Curia Spain S.A.U. Procédé et intermédiaires pour la préparation de viloxazine et d'autres dérivés de morpholine substitués en 2

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH356451A (de) * 1957-04-05 1961-08-31 Geigy Ag J R Verfahren zur Herstellung von neuen Morpholinverbindungen

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2073375A2 (fr) * 1969-11-17 1971-10-01 Ici Ltd

Also Published As

Publication number Publication date
US3714161A (en) 1973-01-30
BE708557A (fr) 1968-06-27
GB1138405A (en) 1969-01-01
DE1695295A1 (de) 1975-03-20
FR7557M (fr) 1969-12-29
DE1695295C2 (de) 1984-01-05
NL157303B (nl) 1978-07-17
CH504452A (de) 1971-03-15
NL6717719A (fr) 1968-07-01

Similar Documents

Publication Publication Date Title
FR7557M (fr)
AT281852B (fr)
BE694568A (fr)
AU428063B2 (fr)
AU424443B2 (fr)
AU414526B2 (fr)
AU433222B2 (fr)
AU421822B2 (fr)
AU417216B2 (fr)
AU415165B1 (fr)
AU1111066A (fr)
AU1144366A (fr)
AU218666A (fr)
AU5895065A (fr)
AU415780B2 (fr)
BE692192A (fr)
BE694374A (fr)
AU411645B2 (fr)
BE694271A (fr)
BE694652A (fr)
BE624001A (fr)
BE693944A (fr)
BE693827A (fr)
BE693513A (fr)
BE692900A (fr)